Pregnancy-induced changes in the long-term pharmacokinetics of 1.1 mg vs. 5 mg folic acid: A randomized clinical trial

Journal of Clinical Pharmacology

Volumn 55, Issue 2, 2015, Pages 159-167

  Shere, Mahvash ^a,b   Nguyen, Patricia ^a,b   Tam, Carolyn ^a,b   Stern, Seth ^a,b   Kapur, Bhushan ^b,c   O'Connor, Deborah L ^a   Koren, Gideon ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

folic acid; periconceptional period; pharmacokinetics; pregnancy; prenatal supplementation; steady state

Indexed keywords

FOLIC ACID;

ADULT; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG DOSE COMPARISON; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; IMMUNOASSAY; INFORMED CONSENT; NORMAL HUMAN; OPEN STUDY; PREGNANCY; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; STEADY STATE; BLOOD; DIET SUPPLEMENTATION; ERYTHROCYTE COUNT; METABOLISM;

ADULT; DIETARY SUPPLEMENTS; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; FOLIC ACID; HUMANS; PREGNANCY;

EID: 84920987678     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.387     Document Type: Article

References (40)

1. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM,. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995; 274 (21): 1698-1702.
2. MRC Vitamin Study Research Group,. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991; 338 (8760): 131-137.
3. Wald NJ, Law MR, Morris JK, Wald DS,. Quantifying the effect of folic acid. Lancet. 2001; 358 (9298): 2069-2073.
4. Smithells RW, Sheppard S, Schorah CJ, et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol. 2011; 40 (5): 1146-1154.
5. McNulty H, Pentieva K, Hoey L, Strain J, Ward M,. Nutrition throughout life: folate. Int J Vitam Nutr Res. 2012; 82 (5): 348-354.
6. Bar-Oz B, Koren G, Nguyen P, Kapur BM,. Folate fortification and supplementation-are we there yet?. Reprod Toxicol. 2008; 25 (4): 408-412.
7. Colapinto CK,. Examining the folate status of Canadians: An analysis of the Canadian Health Measures Survey to assess and guide folate policies. Appl Physiol Nutr Metab. 2014; 39 (3): 401.
8. McNulty B, Pentieva K, Marshall B, et al. Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod. 2011; 26 (6): 1530-1536.
9. Chalmers B, Dzakpasu S, Heaman M, Kaczorowski J,. The Canadian maternity experiences survey: an overview of findings. J Obstet Gynaecol Can. 2008; 30 (3): 217-228.
10. Nguyen P, Tam C, O'Connor DL, Kapur B, Koren G,. Steady state folate concentrations achieved with 5 compared with 1.1 mg folic acid supplementation among women of childbearing age. Am J Clin Nutr. 2009; 89 (3): 844-852.
11. Wilson RD, Johnson JA, Wyatt P, et al. Pre-conceptional vitamin/folic acid supplementation 2007: the use of folic acid in combination with a multivitamin supplement for the prevention of neural tube defects and other congenital anomalies. J Obstet Gynaecol Can. 2007; 29 (12): 1003-1026.
12. Smith AD, Kim YI, Refsum H,. Is folic acid good for everyone? Am J Clin Nutr. 2008; 87 (3): 517-533.
13. Kennedy DA, Stern SJ, Moretti M, et al. Folate intake and the risk of colorectal cancer: a systematic review and meta-analysis. Cancer Epidemiol. 2011; 35 (1): 2-10.
14. Shere M, Zhao XY, Koren G,. The role of social media in recruiting for clinical trials in pregnancy. PLoS One. 2014; 9 (3): e92744.
15. Yetley EA, Pfeiffer CM, Phinney KW, et al. Biomarkers of folate status in NHANES: a roundtable summary. Am J Clin Nutr. 2011; 94 (1): 303S-312S.
16. Gregory JF, III, Williamson J, Liao JF, Bailey LB, Toth JP,. Kinetic model of folate metabolism in nonpregnant women consuming [2H2]folic acid: isotopic labeling of urinary folate and the catabolite para-acetamidobenzoylglutamate indicates slow, intake-dependent, turnover of folate pools. J Nutr. 1998; 128 (11): 1896-1906.
17. Gregory JF, III, Caudill MA, Opalko FJ, Bailey LB,. Kinetics of folate turnover in pregnant women (second trimester) and nonpregnant controls during folic acid supplementation: stable-isotopic labeling of plasma folate, urinary folate and folate catabolites shows subtle effects of pregnancy on turnover of folate pools. J Nutr. 2001; 131 (7): 1928-1937.
18. Sauberlich HE, Kretsch MJ, Skala JH, Johnson HL, Taylor PC,. Folate requirement and metabolism in nonpregnant women. Am J Clin Nutr. 1987; 46 (6): 1016-1028.
19. Pietrzik K, Lamers Y, Bramswig S, Prinz-Langenohl R,. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr. 2007; 86 (5): 1414-1419.
20. Blackburn S, Loper D,. Maternal, Fetal, and Neonatal Physiology: A Clinical Perspective. Philadelphia, PA: W.B. Saunders; 1992.
21. Bailey LB,. Folate in Health and Disease. 2nd edition. Taylor & Francis; Boca Raton, FL 2010.
22. Suh JR, Herbig AK, Stover PJ,. New perspectives on folate catabolism. Annu Rev Nutr. 2001; 21: 255-282.
23. McNulty H, McPartlin JM, Weir DG, Scott JM,. Folate catabolism is increased during pregnancy in rats. J Nutr. 1993; 123 (6): 1089-1093.
24. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG,. Accelerated folate breakdown in pregnancy. Lancet. 1993; 341 (8838): 148-149.
25. Ek J, Magnus EM,. Plasma and red blood cell folate during normal pregnancies. Acta Obstet Gynecol Scand. 1981; 60 (3): 247-251.
26. Caudill MA, Cruz AC, Gregory JF, III, Hutson AD, Bailey LB,. Folate status response to controlled folate intake in pregnant women. J Nutr. 1997; 127 (12): 2363-2370.
27. Caudill MA, Gregory JF, Hutson AD, Bailey LB,. Folate catabolism in pregnant and nonpregnant women with controlled folate intakes. J Nutr. 1998; 128 (2): 204-208.
28. Caudill MA, Bailey LB, Gregory JF, III,. Consumption of the folate breakdown product para-aminobenzoylglutamate contributes minimally to urinary folate catabolite excretion in humans: investigation using [(13)C(5)]para-aminobenzoylglutamate. J Nutr. 2002; 132 (9): 2613-2616.
29. McPartlin J, Courtney G, McNulty H, Weir D, Scott J,. The quantitative analysis of endogenous folate catabolites in human urine. Anal Biochem. 1992; 206 (2): 256-261.
30. Shibata K, Fukuwatari T, Sasaki S, et al. Urinary excretion levels of water-soluble vitamins in pregnant and lactating women in Japan. J Nutr Sci Vitaminol (Tokyo). 2013; 59 (3): 178-186.
31. Faupel-Badger JM, Hsieh CC, Troisi R, Lagiou P, Potischman N,. Plasma volume expansion in pregnancy: implications for biomarkers in population studies. Cancer Epidemiol Biomarkers Prev. 2007; 16 (9): 1720-1723.
32. Kim H, Hwang JY, Kim KN, et al. Relationship between body-mass index and serum folate concentrations in pregnant women. Eur J Clin Nutr. 2012; 66 (1): 136-138.
33. Lipinski P, Stys A, Starzynski RR,. Molecular insights into the regulation of iron metabolism during the prenatal and early postnatal periods. Cell Mol Life Sci. 2013; 70 (1): 23-38.
34. Hovdenak N, Haram K,. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2012; 164 (2): 127-132.
35. Shojania AM, Hornady G,. Folate metabolism in newborns and during early infancy. I. Absorption of pteroylglutamic (folic) acid in newborns. Pediatr Res. 1970; 4 (5): 412-421.
36. Shojania AM, Hornady G,. Folate metabolism in newborns and during early infancy. II. Clearance of folic acid in plasma and excretion of folic acid in urine by newborns. Pediatr Res. 1970; 4 (5): 422-426.
37. Higgins JR, Quinlivan EP, McPartlin J, Scott JM, Weir DG, Darling MR,. The relationship between increased folate catabolism and the increased requirement for folate in pregnancy. BJOG. 2000; 107 (9): 1149-1154.
38. WHO,. Standards for maternal and neonatal care: Prevention of neural tube defects. Integrated Manag Pregnancy Childbirth (IMPAC). 2006; 1-4.
39. Genetics Co, Folic Acid for the Prevention of Neural Tube Defects. Pediatrics. 1999; 104 (2): 325-327.
40. Tam C, McKenna K, Goh YI, et al. Periconceptional folic acid supplementation: a new indication for therapeutic drug monitoring. Ther Drug Monit. 2009; 31 (3): 319-326.